Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A11268 | Pages: NA | Charts: NA | Tables: NA |
Tracheobronchial (airway) stents are those devices utilized to splint narrowed airways open. The narrow or stenotic, airways result from abnormal granulation tissue, metastatic cancers, lung cancer, tuberculosis, infections, lymphoma, or other inflammatory diseases. Stents are somewhat cylindrical in shape and also can be deployed by a bronchoscope. Furthermore, there are various materials that can be used in stents, with different stents having different disease indications. Airway stents can be of two types, permanent or removable. These can be used after the pulmonary physician applies electrocautery, laser, balloon dilatation, or APC to increase the size of airway narrowing. By placing a stent, the airways remain open, allowing adequate airflow and the standard passage of secretions.
COVID-19 scenario analysis:
The need for care of infected population by assisting with management of the infection with medical supplies is increasing. The respiratory support devices such as the atomizers, life-support machine, the oxygen generators, and the monitors are among the majorly used medical devices in clinical treatment. COVID-19 has led to an increase in demand for the medical supplies such as personal protective equipment, which include masks, gloves, protective eyeglasses and others. With the upsurge in number of COVID-19 cases globally, the need for medical supplies will keep on rising among, both from healthcare professionals and the civil population for precautionary measures. Furthermore, manufacturers of these products have a greater opportunity to capitalize this increased demand of medical supplies, to allow adequate and continuous supply of personal protective equipment in the market.
Rise in prevalence of respiratory disorders globally and increase in preference for minimally invasive procedures drives the market growth. Furthermore, surge in demand for customized lung stents with the development of biodegradable and drug-eluting stents offers lucrative growth opportunities for the players in the industry. However, rise in availability of alternative treatment may hinder the growth of the industry in the near future.
The launch of new products according to the key market players would help the market gain a lucrative growth in the forecast period. For instance, in January 2020, the U.S. Food and Drug Administration (FDA) had cleared the patient-specific airway stents. The stents are used to help in keeping open the airways of patients who are suffering with serious breathing disorders, such as those caused by tumors, inflammation, trauma or other masses. Until now, the patient-specific devices were being implanted under FDA’s compassionate use program, which permits patients who have failed all accessible forms of treatment to receive new ones not yet available to the public.
In October 2015, Boston Scientific received FDA approval for its Watchman device, and announced approval for another cardiovascular device predictable to be a major driver of sales over the next year. Furthermore, the Synergy drug-eluting stent. The Synergy Bioabsorbable Polymer Drug-Eluting Stent System is designed to allow better and quicker healing of the inside of an artery in patients. The device involves metal stent coated on the outside with a polymer that helps in delivering the anti-inflammatory drug, Everolimus, the same drug used on the company’s Promus family of drug-eluting stents.
The growth in the number of mergers and acquisition would propel the market in the coming years. For instance, in June 2018, Cook Medical had partnered with Taewoong Medical in order to distribute a selection of stents in to the United States. The new partnership includes the Niti-S through the Scope (TTS) Esophageal Stent, which is the flagship product of the South Korean company’s Niti-S Self-Expandable line of metal GI stents. Cook Medical will begin distributing the Taewoong portfolio.
In May 2018, Merit Medical Systems, Inc., which is a leading manufacturer and also marketer of proprietary disposable devices that is used in interventional, diagnostic and therapeutic procedures, particularly in radiology, cardiology, oncology, endoscopy, and critical care announced its execution of a universal distribution agreement with the NinePoint Medical, Inc. and the progress of a strategic alliance between its Merit Endotek division and NinePoint Medical. Additionally, this alliance includes a strategic investment for NinePoint Medical’s Nvision VLE Imaging System with real-time targeting.
Key benefits of the report:
Questions answered in the airway stent/lung stent market research report:
Key Market Segments
Key Market Players